Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03947450 · ClinicalTrials.gov registry record · Phase 2
Autologous Volar Fibroblast Injection Into the Stump Site of Amputees
A Phase 2 study of Amputation and Skin Wound, sponsored by Johns Hopkins University.
- Recruiting
- Registry status
- Phase 2
- Development phase
- 50
- Enrollment target
- 1
- Study location
NCT03947450 is a Phase 2 study of Amputation and Skin Wound that is actively recruiting participants, run by Johns Hopkins University. The registered enrollment target is 50 participants, below the 132-participant average among 65 other Amputation trials with a reported enrollment target (62% lower). The trial reports 1 study location across 1 state.
The verdict
NCT03947450, a Phase 2 study of Amputation and Skin Wound, is actively recruiting participants, sponsored by Johns Hopkins University.
- RECRUITING
- Registry status
- Phase 2
- Development phase
- 50 participants
- Enrollment target
- 1
- Study location
Study Summary
This study is a clinical trial testing the safety and efficacy of volar fibroblast (skin cells from the palm or sole) injections for thickening the epidermal (skin) layer at the stump site in people with below the knee amputations. The study will enroll adults seen at Johns Hopkins.
Conditions Studied
Interventions
- BIOLOGICAL Placebo
- BIOLOGICAL Autologous Skin Fibroblasts
Study Locations (1)
Maryland
- Department of Dermatology at Johns Hopkins University - Baltimore
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 50 participants |
| Start Date | 2019-09-05 |
| Est. Completion | 2028-04-01 |
| Phase | Phase 2 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT03947450
The ClinicalTrials.gov registry entry for NCT03947450 describes a study currently listed as recruiting, categorized as Phase 2. The registered enrollment target is 50 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 132-participant average among 65 other Amputation trials with a reported enrollment target (62% lower). The listed sponsor is Johns Hopkins University, which has 1,448 total studies on file at ClinicalTrials.gov.
The record links to 3 conditions, with Amputation appearing as the primary indexed condition, and to 2 interventions - of which Placebo is the first listed.
NCT03947450 reports 1 study location spanning 1 distinct geographic area - top geographies include Maryland.
Frequently Asked Questions
What is clinical trial NCT03947450 about?
NCT03947450 is a clinical study titled "Autologous Volar Fibroblast Injection Into the Stump Site of Amputees". This study is a clinical trial testing the safety and efficacy of volar fibroblast (skin cells from the palm or sole) injections for thickening the epidermal (skin) layer at the stump site in people with below the knee amputations. The study will enroll adults seen at Johns Hopkins.
What is the current status of trial NCT03947450?
This trial is currently recruiting. It is a Phase 2 study. The enrollment target is 50 participants. The study started on 2019-09-05. Estimated completion is 2028-04-01.
What conditions does trial NCT03947450 study?
This clinical trial studies the following conditions: Amputation, Skin Wound, Stem Cell.
What interventions are being tested in trial NCT03947450?
The interventions under investigation include: Placebo (BIOLOGICAL), Autologous Skin Fibroblasts (BIOLOGICAL).
Who is sponsoring clinical trial NCT03947450?
This trial is sponsored by Johns Hopkins University, which has 1,448 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT03947450 being conducted?
This trial has 1 study location across Maryland. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Amputation
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
Deploying Digital Prosthetic Interface Technology and Exercise in Dysvascular Amputees
RECRUITING · Phase 2
-
Multicenter Trial Evaluating the Safety and Efficacy of Autologous Volar Fibroblast Injection Into the Terminal Limb of Amputees.
RECRUITING · Phase 2
-
Human Penile Allotransplantation
RECRUITING · Phase 2
-
Dysvascular Amputation Self-Management of Health
COMPLETED · Phase 2
-
Evaluation of Myoelectric Implantable Recording Array (MIRA) in Participants With Transradial Amputation
RECRUITING · NA
-
Efficacy and Mechanisms of Virtual Reality Treatment of Phantom Leg Pain.Home-Based Treatment
RECRUITING · NA
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.